miR-330-3p alleviates the progression of atherosclerosis by downregulating AQP9.


Journal

Functional & integrative genomics
ISSN: 1438-7948
Titre abrégé: Funct Integr Genomics
Pays: Germany
ID NLM: 100939343

Informations de publication

Date de publication:
07 Mar 2023
Historique:
received: 15 12 2022
accepted: 23 02 2023
revised: 20 02 2023
entrez: 6 3 2023
pubmed: 7 3 2023
medline: 9 3 2023
Statut: epublish

Résumé

Atherosclerosis (AS) is the main cause of cardiovascular diseases. However, the role of AQP9 in AS is not well understood. In the present study, we predicted that miR-330-3p might regulate AQP9 in AS through bioinformatics analysis, and we established AS model using ApoE

Identifiants

pubmed: 36879069
doi: 10.1007/s10142-023-01001-7
pii: 10.1007/s10142-023-01001-7
doi:

Substances chimiques

MicroRNAs 0
AQP9 protein, human 0
Aquaporins 0
MIRN330 microRNA, human 0
Aqp9 protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Subventions

Organisme : Key Project of Anhui Natural Science Foundation in Higher Education
ID : 2022AH051514
Organisme : Key Project of Anhui Natural Science Foundation in Higher Education
ID : 2022AH051514
Organisme : Key Project of Anhui Natural Science Foundation in Higher Education
ID : 2022AH051514
Organisme : Key Project of Anhui Natural Science Foundation in Higher Education
ID : 2022AH051514
Organisme : Key Project of Anhui Natural Science Foundation in Higher Education
ID : 2022AH051514
Organisme : Key Project of Anhui Natural Science Foundation in Higher Education
ID : 2022AH051514
Organisme : Key Project of Anhui Natural Science Foundation in Higher Education
ID : 2022AH051514

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Cai C, Wang C, Ji W et al (2013) Knockdown of hepatic aquaglyceroporin-9 alleviates high fat diet-induced non-alcoholic fatty liver disease in rats. Int Immunopharmacol 15:550–556. https://doi.org/10.1016/j.intimp.2013.01.020
doi: 10.1016/j.intimp.2013.01.020 pubmed: 23415870
Chen T, Yang Z, Liu C et al (2019) Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330–3p. Cell proliferation 52:e12548. https://doi.org/10.1111/cpr.12548
doi: 10.1111/cpr.12548 pubmed: 30507050
Cheng Y, Zhu H, Gao W (2020) MicroRNA-330–3p represses the proliferation and invasion of laryngeal squamous cell carcinoma through downregulation of Tra2β-mediated Akt signaling. Mol Cell Probes 52:101574. https://doi.org/10.1016/j.mcp.2020.101574
doi: 10.1016/j.mcp.2020.101574 pubmed: 32289378
Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351–379. https://doi.org/10.1146/annurev-biochem-060308-103103
doi: 10.1146/annurev-biochem-060308-103103 pubmed: 20533884
Frostegård J (2013) Immunity, atherosclerosis and cardiovascular disease. BMC Med 11:117. https://doi.org/10.1186/1741-7015-11-117
doi: 10.1186/1741-7015-11-117 pubmed: 23635324 pmcid: 3658954
Hill M, Tran N (2021) miRNA interplay: mechanisms and consequences in cancer. Disease models & mechanisms 14. https://doi.org/10.1242/dmm.047662
Inouye M, Ripatti S, Kettunen J et al (2012) Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet 8:e1002907. https://doi.org/10.1371/journal.pgen.1002907
doi: 10.1371/journal.pgen.1002907 pubmed: 22916037 pmcid: 3420921
Jiang H, Zhang J, Du Y et al (2015) microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator. Atheroscler 243:523–532. https://doi.org/10.1016/j.atherosclerosis.2015.10.026
doi: 10.1016/j.atherosclerosis.2015.10.026
Jing J, Sun J, Wu Y et al (2021) AQP9 Is a prognostic factor for kidney cancer and a promising indicator for M2 TAM polarization and CD8+ T-cell recruitment. Front Oncol 11:770565. https://doi.org/10.3389/fonc.2021.770565
doi: 10.3389/fonc.2021.770565 pubmed: 34804972 pmcid: 8602816
Lebeck J, Cheema MU, Skowronski MT et al (2015) Hepatic AQP9 expression in male rats is reduced in response to PPARalpha agonist treatment. Am J Physiol Gastrointest Liver Physiol 308:G198-205. https://doi.org/10.1152/ajpgi.00407.2013
doi: 10.1152/ajpgi.00407.2013 pubmed: 25477377
Libby P (2021) The changing landscape of atherosclerosis. Nat 592:524–533. https://doi.org/10.1038/s41586-021-03392-8
doi: 10.1038/s41586-021-03392-8
Ren L, Li P, Li Z et al (2022) AQP9 and ZAP70 as immune-related prognostic biomarkers suppress proliferation, migration and invasion of laryngeal cancer cells. BMC Cancer 22:465. https://doi.org/10.1186/s12885-022-09458-8
doi: 10.1186/s12885-022-09458-8 pubmed: 35477402 pmcid: 9047300
Rojek AM, Skowronski MT, Fuchtbauer EM et al (2007) Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc Natl Acad Sci U S A 104:3609–3614. https://doi.org/10.1073/pnas.0610894104
doi: 10.1073/pnas.0610894104 pubmed: 17360690 pmcid: 1805577
Verkerk AO, Lodder EM, Wilders R (2019) Aquaporin channels in the heart-physiology and pathophysiology. International journal of molecular sciences 20. https://doi.org/10.3390/ijms20082039
Verkman AS, Matthay MA, Song Y (2000) Aquaporin water channels and lung physiology. Am J Physiol Lung Cell Mol Physiol 278:L867-879. https://doi.org/10.1152/ajplung.2000.278.5.L867
doi: 10.1152/ajplung.2000.278.5.L867 pubmed: 10781416
Wu J, Wang C, Ding H (2020) LncRNA MALAT1 promotes neuropathic pain progression through the miR1545p/AQP9 axis in CCI rat models. Mol Med Rep 21:291–303. https://doi.org/10.3892/mmr.2019.10829
doi: 10.3892/mmr.2019.10829 pubmed: 31746418
Xu S, Schlüter PM, Grossniklaus U et al (2012) The genetic basis of pollinator adaptation in a sexually deceptive orchid. PLoS genetics 8:e1002889. https://doi.org/10.1371/journal.pgen.1002889
doi: 10.1371/journal.pgen.1002889 pubmed: 22916031 pmcid: 3420943
Yu J, Fan Q, Li L (2021) The MCM3AP-AS1/miR-126/VEGF axis regulates cancer cell invasion and migration in endometrioid carcinoma. World J Surg Oncol 19:213. https://doi.org/10.1186/s12957-021-02316-0
doi: 10.1186/s12957-021-02316-0 pubmed: 34256796 pmcid: 8278665
Zhang S, Li L, Chen W et al (2021) Natural products: the role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytother Res : PTR 35:2945–2967. https://doi.org/10.1002/ptr.7002
doi: 10.1002/ptr.7002 pubmed: 33368763
Zhang B, Lv D, Chen Y et al (2022) Aquaporin-9 facilitates liver regeneration following hepatectomy. Redox biology 50:102246. https://doi.org/10.1016/j.redox.2022.102246
doi: 10.1016/j.redox.2022.102246 pubmed: 35086002 pmcid: 8802049
Zhang Z, Liang K, Zou G, et al. (2018) Inhibition of miR-155 attenuates abdominal aortic aneurysm in mice by regulating macrophage-mediated inflammation. Bioscience reports 38. 10.1042/bsr20171432
Zhou M, Ren P, Zhang Y et al (2019) Shen-Yuan-Dan capsule attenuates atherosclerosis and foam cell formation by enhancing autophagy and inhibiting the PI3K/Akt/mTORC1 signaling pathway. Front Pharmacol 10:603. https://doi.org/10.3389/fphar.2019.00603
doi: 10.3389/fphar.2019.00603 pubmed: 31214032 pmcid: 6554665

Auteurs

Erbo Shan (E)

The First Affiliated Hospital of Jinan University, Guangzhou, China.
The Second Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Yuanyuan Yu (Y)

The Second Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Wenbo Tang (W)

Department of Vascular Surgery, the First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, 233004, China.

Wei Wang (W)

The Second Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Xiangkui Wang (X)

Department of Vascular Surgery, Huaibei General Miner Hospital, Huaibei, China.

Shaobo Zhou (S)

The Second Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Yong Gao (Y)

The First Affiliated Hospital of Jinan University, Guangzhou, China. gaoyongbbyxy@163.com.
Department of Vascular Surgery, the First Affiliated Hospital of Bengbu Medical College, No. 287 Changhuai Road, Bengbu, 233004, China. gaoyongbbyxy@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH